Rebirth 1984: Starting from the development of Hanka

Chapter 241 Traditional Chinese Medicine

From the second day on, Wanjiang Real Estate Company once again demonstrated the aggressive spirit it had when it first opened up the real estate market in Japan——barbaric expansion!

There is a saying, "Strategic expansion, talents first".

Many companies expand blindly and fail in the end. To sum up, there are roughly two main internal reasons: the first is that the talents are not supported, and the second is that the management system is not supported.

The management system of Wanjiang Real Estate is relatively complete, but it lacks talents. After all, Wanjiang Real Estate is going to enter the domestic real estate market in an all-round way, involving many projects, so it needs a lot of talents.

Therefore, the first step of Wujiang Real Estate Company is to recruit people.

Although Wanjiang Real Estate Company has also cultivated some talents, it is far from enough.

Architectural model designers, estimators, engineering cost engineers, marketing planners, accountants, human resource management professionals, project management talents, etc... are all the personnel that Wanjiang Real Estate Company urgently needs.

The recruitment advertisement of Wanjiang Real Estate Company soon appeared on the Internet, TV stations, newspapers and other media.

Due to the high salary of Wanjiang Real Estate, many people try to apply for the position of Wanjiang Real Estate Company.

……

There is no doubt that the real estate industry is very profitable.

Although this may cause housing prices to rise in the future, but mastering a huge real estate company can at least exert influence on the industry and make some changes to the bad atmosphere.

At this moment, the entire Wanjiang Real Estate Company is running efficiently like a machine. The CEO Xu Shengzhe is already busy, but the spirit on his face has not decreased at all.

After more than a month of preparation.

Xu Shengzhe organized [-] teams to go to [-] cities across the country to open up the real estate market, namely Shanghai, BJ, Shenzhen, Guangzhou, Chongqing, Suzhou, Chengdu, Hangzhou, Nanjing, Wuhan, Tianjin, Ningbo, Qingdao, Changsha, Wuxi , Zhengzhou, Foshan, Nantong, Jinan and Xi'an.

This is the arrangement of the first batch of personnel. Wanjiang Real Estate will form more teams and go to more cities in the future.

Wanjiang Real Estate Company is not short of money, and its expansion speed is as fast as lightning compared with other real estate companies.

Xu Shengzhe is full of hope for the future of Wanjiang Real Estate Company and has formulated a very grand plan.

Of course, in the early stage, land will be the main focus.

Right now, the charitable deeds of Wujiang Group are deeply rooted in the hearts of the people. As long as the local government knows that Wanjiang Real Estate Company is a subsidiary of Wujiang Group, it is not easy for Wanjiang Real Estate to acquire land at a low price.Furthermore, the local government also hopes that Wanjiang Real Estate will carry out real estate development after acquiring the land, so as to prosper and stimulate the local economy and achieve a win-win situation.

……

Zhao Ye really dared not imagine that with his own support, Wanjiang Real Estate Company would become several Wanda Groups, at least five or six Wanda Groups, perhaps more than ten would not be impossible.

This year is 1994, which is also the first year of Wanda Group's establishment. Wang Jianlin probably never dreamed that Wanda Group has become a unit of measurement in Zhao Ye's mouth. (Wang Jianlin: Nima, do I want to lose face?)
Zhao Ye is very satisfied with Xu Shengzhe's plan. Once he makes a move, it will be extraordinary. These 20 cities are the top [-] cities in the previous life, and their real estate market naturally has great potential for development!

At this time, Zhao Ye picked up another document on the table, which contained a research report on investing in the construction of Wujiang Hospital.

In Zhao Ye's plan, he will take the lead in building a modern comprehensive third-class first-class hospital in BJ, Shanghai, Guangzhou, and Shenzhen, which integrates medical treatment, teaching, and scientific research. The investment in each hospital is no less than 30 billion US dollars. .

At this time, the location of the hospital has not been determined, but it will generally cooperate with Wanjiang Real Estate to increase the value of Wanjiang Real Estate Development Project.

Generally speaking, real estate projects close to hospitals, schools, shopping malls, and government agencies have great potential for appreciation.

With the support of Wujiang Group, Wanjiang Real Estate can at least guarantee the first three points in its projects.

For the time being, the construction of Wujiang Hospital is not the most urgent thing.

However, the development of Wujiang Medicine can be put on the agenda.

The pharmaceutical industry is known as the "three high" industry, namely high profit, high return, and high investment. The industry generally believes that it takes 10 years and an investment of 10 billion US dollars for a new drug to go from research and development to launch.Therefore, the pharmaceutical industry has become a monopoly industry with strong barriers and high technological content. Generally, small and medium-sized enterprises cannot afford high R&D costs, and large companies dare not invest rashly. Pharmaceutical R&D projects are high-risk projects with a success rate of less than 10%. .In view of this, China's pharmaceutical industry started not too late, but R&D investment cannot keep up, capital accumulation is low, marketing is more important than scientific research, and generic drugs are the mainstay.

At present, most of the profits in the pharmaceutical market are occupied by foreign pharmaceutical companies.The research and development of new human drugs, especially those in the field of cancer and cardiovascular and cerebrovascular diseases, are basically contributed by the Western world.

According to the Beijing News, in 2022, Pfizer's net profit will reach 313 billion US dollars! ! !It is more than six times the total profit of China's top ten pharmaceutical companies in 2020!

How exaggerated is this data!It is extremely shocking!
Chinese medicine has been dumped N streets by American pharmaceutical companies! !

If you don't rise up to catch up, the gap will only get bigger and bigger.

Zhao Ye felt that he had the opportunity to change China's pharmaceutical industry, not only to drive foreign medicines out of the Chinese market, but also to enter the international pharmaceutical market and grab the market share of European and American pharmaceutical companies.

At this time, Wujiang Group has paid headhunting companies to recruit people from major pharmaceutical companies around the world.

It is expected that Wujiang Pharmaceutical Company will become full of talents in a short time.

Zhao Ye also placed high hopes on Wujiang Pharmaceutical Company. There is no upper limit on investment, and the development of three major categories of drugs (traditional medicine, biological medicine, and chemical medicine) can be carried out at the same time.

Traditional Chinese medicine includes Chinese herbal decoction pieces, Chinese patent medicines and Chinese herbal medicines.

Biologics include vaccines, serum and blood products.

Chemical drugs include chemical raw materials and their preparations, antibiotics, etc.

The diseases treated by these three types of drugs are different, and the drugs can be prescribed according to the actual situation.

Right now, Wujiang Pharmaceutical Company's top priority is to apply for a patent on traditional Chinese medicine.

Just as South Korea likes to use Chinese culture to apply for world heritage, Japan is good at preempting the patent registration of traditional Chinese medicine prescriptions internationally.

South Korea steals culture and Japan steals traditional Chinese medicine. It can be said that there is a clear division of labor.

Not only that, Japan even registered patents for the herbs used to make traditional Chinese medicine, which is extremely shameless.

In the previous life, Japan preemptively registered more than 70% of the patents of Chinese patent medicines in the world. In contrast, China’s share of Chinese medicine patents only accounted for 0.3%.In addition, Japan has monopolized 90% of the global Chinese medicine market.Traditional Chinese medicine has become Japan's gold-absorbing weapon.

Unfortunately, in this life, the conspiracy of Japanese pharmaceutical companies will not succeed!

Wujiang Pharmaceutical Company will carry the banner of Chinese traditional medicine and promote Chinese patent medicine to the world! ! !
……

With the help of Wujiang Group's huge resources, Wujiang Pharmaceutical Company has counted how many Chinese medicine companies and how many Chinese medicine formulas there are in the country.

Traditional Chinese medicine has a long history. There is no need for Wujiang Pharmaceutical Company to re-develop traditional Chinese medicine products. It only needs to invest in those time-honored pharmaceutical companies, such as Tongrentang, Jiuzhitang, Guangyuyuan, Yunnan Baiyao, Chen Liji, Huiren, Dong'e, Zhongjing, Half the Sky , Baiyun Mountain, Renhe, Yangwuji, Harbin Yao, Pan Gaoshou, Jingxiutang, Caizhilin, Ma Yinglong, etc...

Perhaps with the influence of Wujiang Pharmaceutical Company, traditional Chinese medicine will also rise again, recast its glory, and become the pride of the Chinese people!
Now, Zhao Ye can't wait to see the rise of Chinese medicine.Over the past hundred years, the west wind has prevailed against the east wind, suppressing our treasure - traditional Chinese medicine very ruthlessly, and some people with ulterior motives specialize in fawning on the outside and suppressing the inside, resulting in the failure of our excellent traditional culture to develop.

Wujiang Pharmaceutical Company is now looking for, collecting, and sorting out the remaining wealth of the ancestors. The day of the rise of Chinese medicine should not be far away.

……

At this time, Wujiang Pharmaceutical Company seconded the staff of the parent company to start the investment plan.

Zhao Ye made a big deal and directly invested 500 billion yuan in Wujiang Pharmaceutical Company to invest in a time-honored traditional Chinese medicine company. If it is not enough, he will invest more.

Fan Bohan, general manager of Tongrentang Company, was surprised that people from Wujiang Group would come to their company to discuss business.

"Mr. Fan, hello, my name is Zhou Weimin, and I want to invest in Tongrentang on behalf of Wujiang Pharmaceutical Company!" Zhou Weimin, the representative of Wujiang Group, said straight to the point.

Fan Bohan was taken aback when he heard the words. He obviously didn't expect the other party to have this purpose. Before he could open his mouth, the other party said: "Tong Ren Tang's revenue last year was only more than 4 million RMB. Wujiang Pharmaceutical Company is willing to invest 49 million RMB in Tong Ren Tang, accounting for [-]% of the shares!"

Investing 49 million and only accounting for [-]% of the shares? ? ?

Fan Bohan couldn't help clicking his tongue.

"Mr. Zhou, hello. Tongrentang is a central enterprise. The investment is too big for me to make a decision." Fan Bohan shook his head.

Zhou Weimin smiled and said, "I know that Tongrentang is a state-owned enterprise, so Mr. Fan can report this matter to the higher-ups."

"Okay, I will report it to the higher authorities." Fan Bohan nodded and said, but couldn't help asking, "Mr. Zhou, may I ask, why does Wujiang Pharmaceutical Company invest in Tongrentang Company?"

Zhou Weimin replied: "Because Wujiang Pharmaceutical Company intends to promote Chinese medicine and traditional Chinese medicine, I hope that one day, Chinese medicine halls can spread all over the land of China again, benefiting the people and recreating the glory of the past."

After a pause, Zhou Weimin continued, "Tongrentang was founded in 1669 and is one of the most famous and time-honored brands in the Chinese medicine industry in the country! To tell you the truth, our Wujiang Pharmaceutical Company not only wants to invest in Tongrentang, but also other time-honored Chinese medicine companies." Pharmaceutical companies. At present, Chinese medicine is declining, and Chinese medicine patents are being registered by Japanese pharmaceutical companies. The situation is relatively severe, but domestic pharmaceutical companies generally lack awareness of the importance of patents to pharmaceutical companies. If things go on like this, Japanese pharmaceutical companies rush to register Chinese medicine There are more and more patents, and by then, the entire Chinese medicine industry in China will be controlled by Japan!"

Speaking of this, Zhou Weimin's face became serious.

He has studied in Japan and been in contact with Japanese proprietary Chinese medicines, so he understands Japan's determination to develop Chinese patent medicines very well.

Traditional Chinese medicine is the quintessence of China, but in China, Chinese medicine is crazily belittled, while in Japan, Chinese patent medicine is very popular, which is quite ironic.

When Zhou Weimin learned of the Chinese medicine investment plan of Wujiang Pharmaceutical Company, he volunteered to participate in the plan.

Although Fan Bohan also knew the importance of patents, he didn't know much.

Many of Tong Ren Tang's traditional Chinese medicines have hardly applied for patents.

……

Wujiang pharmaceutical companies generally focus on investment in state-owned or central enterprises.

For private companies, as much as possible direct acquisition, followed by investment.

Jiuzhitang is a private company, and the people sent by Wujiang Pharmaceutical Company expressed their intention to acquire it.

As a private company, Jiuzhitang is naturally not as large as Tongrentang. Later, it was acquired by Yongjin Group, and Wei Dong, a financial genius, became the head of Jiuzhitang. This event will happen in the next few years. Big hit.It's more or less unexpected that a genius from the financial world sits at the top of a famous pharmaceutical company!
Of course, Jiuzhitang had no resistance in the face of the acquisition of Wujiang Pharmaceutical Company. The shareholders of Jiuzhitang could not help accepting the generous offer of Wujiang Pharmaceutical Company.

At the same time, more than a dozen private pharmaceutical companies, including Qianjin Pharmaceutical, Huiren, and Renhe, have accepted the acquisition of Wujiang Pharmaceutical Company.

There is no way, the money is very well paid.

State-owned enterprises such as Tongrentang, Baiyunshan Chenliji Pharmaceutical Factory, Guangyuyuan, and Pien Tze Huang also chose to accept investment from Wujiang Pharmaceutical Company, but the shares did not exceed 50%, but the minimum shareholding amount also reached 25%.

(End of this chapter)